Fierce Pharma Week made one thing clear: life sciences does not have an innovation problem. It has an activation problem.
Across the industry, leaders have more data, more technology, more strategic options and more AI capability than ever before. Yet many organizations still struggle to turn those advantages into different decisions, stronger execution and measurable results.
RISE defines the Action Gap™ as the measurable distance between an organization's commercial intent and the decisions, behaviors and customer interactions that actually occur in the field. It appears when strategy is clear at the leadership level but does not translate into repeatable work.
How can pharma close the gap between commercial strategy and field execution?
Connect five stages in one operating loop: Strategy → Translation → Enablement → Execution → Feedback. Set the commercial priority, turn it into specific field choices, equip and coach teams, observe the work, and use field evidence to refine the strategy and support.
The RISE Action Gap™ framework
- Strategy: Name the customer outcome, the priority segments and the few choices that matter most.
- Translation: Specify what each field role should do differently in accounts, conversations and handoffs.
- Enablement: Give teams the knowledge, tools, practice and manager coaching to make those choices confidently.
- Execution: Embed the behavior in territory planning, customer interactions, workflows and operating cadence.
- Feedback: Compare observed behaviors and customer outcomes with the intent; remove barriers and adjust the next cycle.
This is a practical expression of commercial excellence at RISE: aligning decisions, capabilities and management routines so performance can be repeated.
The Signal
The Action Gap is showing up everywhere.
Great strategy never fully reaches the field. Commercial plans look compelling in PowerPoint but lose momentum in execution. AI pilots prove that a technology works without changing how people work. Transformation becomes another initiative competing for attention.
The pattern is consistent: the organization knows what it wants to accomplish, but the work itself does not change enough to produce the intended result.
Why It Matters
Life-science organizations are surrounded by innovation: new platforms, new data, new AI capabilities, new commercial models and new ways to engage customers. But innovation creates value only when it changes behavior, decisions or workflow.
A strategy that does not translate into clear choices remains an aspiration. A technology that does not enter the operating rhythm remains a pilot. An insight that does not influence a decision remains information.
The cost is not simply slower execution. The Action Gap consumes investment, weakens confidence and teaches teams to wait out the next initiative. Over time, the distance between leadership intent and day-to-day reality becomes part of the culture.
The Curbside View
The answer is not another layer of strategy. It is disciplined activation.
The most useful starting point is to separate three distinct leadership tasks: Assess, Address and Activate.
Assess what is really happening. Not what the strategy says should be happening and not only what the dashboard suggests. Look at the decisions, handoffs, behaviors and customer experiences where the work actually occurs.
Address what is getting in the way. Sometimes the barrier is strategy. Sometimes it is process, technology, capability or decision rights. Often, too many priorities are competing for the same attention, leaving teams unclear about what matters now.
Then activate. Turn strategy into behaviors. Turn technology into workflows. Turn insight into decisions. Establish ownership, measures and a practical operating cadence that makes the new way of working visible and repeatable.
Transformation does not happen in the boardroom. It happens in the work.
The Move
Choose one consequential priority where the organization already knows what should happen but execution remains inconsistent.
Map the current reality. Identify the few decisions and behaviors that must change. Name the owners. Remove the most important barriers. Build the new expectations into the meetings, workflows, measures and coaching that shape everyday performance.
Then watch the work, not merely the launch plan. Ask whether decisions are improving, whether the workflow is changing and whether people have enough clarity and support to sustain the new behavior.
Closing the Action Gap is rarely a single communication event. It is a leadership discipline that connects intent to execution until the new way of working becomes the normal way of working.
What this looks like in practice
In RISE's work with RxVantage, the focus was on helping commercial teams turn platform capabilities into field-ready conversations and consistent execution through the REP training program. The program connected product understanding, customer context, practice and certification to the work teams do with life-science partners. It illustrates the Translation → Enablement → Execution stages; results depend on adoption and ongoing measurement.
Listen to RISE Unpacked Episode 01 on the Action Gap™ for a deeper conversation about strategy, field behavior and reinforcement.
Frequently asked questions
What is the Action Gap™ in pharma?
It is the distance between a commercial strategy's intended outcome and what field teams consistently decide and do with customers. RISE uses the term to examine the handoffs between planning, enablement, daily execution and evidence from the field.
How should a pharma company diagnose its strategy-to-execution gap?
Pick one priority, define the field behaviors it requires, and compare them with observed account plans, customer conversations, manager coaching and outcomes. Ask where the chain breaks: unclear choices, insufficient practice, workflow friction or weak feedback.
What role does commercial excellence play?
Commercial excellence creates the operating discipline around the strategy: clear roles, repeatable processes, useful enablement, coaching and measures that show whether the intended behavior is happening.
How do leaders know the gap is closing?
Track leading signals such as adoption of the target behaviors and quality of customer interactions alongside the business outcomes the strategy aims to improve. Review both with field leaders, then adjust enablement and workflows in response.
One Question to Take With You
That is where the Action Gap begins—and where activation can create the fastest value.
Continue the conversation
Where are you seeing strong strategy or innovation but limited activation? I'd welcome the conversation.
carl@therisegroup.ai